We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Amgen to launch ‘biosimilar’ version of medicine that has generated $200bn in sales since launch
Millions of pounds are being invested to turn scientific research into global companies. But some founders say they have to give up too much equity
Platform aims to increase transparency on provenance of pieces from smaller makers, boosting resale potential
Getty Images and others are challenging AI companies’ use of copyrighted images to train their image-generating algorithms
Skynet hits the books
Bloc asks global body to convene panels to rule on two trade disputes
Ending of pharma group’s IP truce spells fight for future of mRNA technology
Pharma company still ‘eager’ to collaborate with Beijing, despite collapse of initial talks
Lawsuit centres on US company’s purchase of start-up Nuvia
Foreign companies are finally winning the battle to trademark names — but is the cost worth it?
US biotech claims rival Covid vaccine makers infringed patents underpinning jabs developed to combat the pandemic
Company is being sued over allegations it overcharged millions of customers
A decision by the Japan Patent Office appears to credit the consumer with more discernment than trademark owners do
It’s not just million-dollar paintings. The race is on to track down the everyday objects that are looted in war
Ruling will enable luxury British shoemaker to sell in country directly for first time
Pharma group seeks compensation from Covid vaccine maker for alleged IP infringements
Landmark case signals shift for consumers towards mass lawsuits over antitrust breaches
The top firms for 2022 revealed. Plus: Russia’s patents grab; China flexes muscle across borders; nations urged to waive vaccine IP; green patents slow despite net zero goals; and the artificial intelligence debate
Intellectual property offices globally are exploring how they can help the development of low-carbon technologies
Companies could be incentivised to keep inventions as trade secrets
Anti-suit injunctions in telecom cases reflect growing assertiveness by rising superpower
Partners offered above-the-odds pay and multiyear salary guarantees
Only 1 per cent of the 10bn jabs delivered so far have been in low-income countries
Some lawyers also fear trademarks, copyright and even physical property could be next
Clients and peers feed into research to create the latest listing of the continent’s top intellectual property firms
International Edition
